We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

68 hedge funds and large institutions have $34.4M invested in Matinas BioPharma in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

440% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 5

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

6% more funds holding

Funds holding: 64 → 68 (+4)

0.22% more ownership

Funds ownership: 0.37% → 0.58% (+0.22%)

49% less capital invested

Capital invested by funds: $67.4M → $34.4M (-$33M)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
27
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$13.6M
2
Victory Capital Management
Victory Capital Management
Texas
+$7.75M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.74M
4
BC
Boxer Capital
California
+$1.56M
5
BBA
Baker Bros. Advisors
New York
+$1.35M

Top Sellers

Rank Fund Capital Flow
1
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$454K
2
OAM
Oxford Asset Management
United Kingdom
-$251K
3
ECM
ExodusPoint Capital Management
New York
-$180K
4
SG Americas Securities
SG Americas Securities
New York
-$101K
5
IWAG
Integer Wealth Advisors Group
Georgia
-$82K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIG
26
Sargent Investment Group
Maryland
$115K +$164K +2,724 +244%
SG Americas Securities
27
SG Americas Securities
New York
$100K -$101K -1,668 -33%
CAG
28
Crestwood Advisors Group
Massachusetts
$86K – – –
State Street
29
State Street
Massachusetts
$76K +$133K +2,200 +659%
WG
30
Winton Group
United Kingdom
$65K -$68.8K -1,140 -34%
PAG
31
Private Advisor Group
New Jersey
$64K +$46.2K +765 +56%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$61K +$123K +2,044 New
PTP
33
Platform Technology Partners
New York
$60K – – –
BJL
34
Brighton Jones LLC
Washington
$54K +$48.3K +800 +80%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$50K – – –
CDH
36
Charles D. Hyman
$48K – – –
HF
37
HRT Financial
New York
$43K +$88.3K +1,463 New
JP Morgan Chase
38
JP Morgan Chase
New York
$27K – – –
Bank of America
39
Bank of America
North Carolina
$25K +$49.8K +824 New
Stifel Financial
40
Stifel Financial
Missouri
$24K +$5.25K +87 +12%
Charles Schwab
41
Charles Schwab
California
$22K – – –
JG
42
Jefferies Group
New York
$22K +$44.9K +744 New
AWA
43
Arete Wealth Advisors
Illinois
$18K – – –
CWM
44
CCG Wealth Management
California
$18K – – –
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$16K +$10.9K +180 +50%
Janney Montgomery Scott
46
Janney Montgomery Scott
Pennsylvania
$14K +$9.66K +160 +53%
AGM
47
Alpine Global Management
New York
$12K -$49K -812 -67%
DAS
48
Dynamic Advisor Solutions
Arizona
$12K – – –
RC
49
RegentAtlantic Capital
New Jersey
$12K – – –
NRS
50
Neville Rodie & Shaw
New York
$11K – – –
1
2
3

MTNB Hedge Fund Activity: Q1 2020 in Review

68 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q1 2020, worth a combined $34.4M — down 49% from $67.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MTNB positions and 8 closed out — a net gain of 6 holders — while 27 added to existing stakes and 5 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $13.6M. The largest seller was CIBC Private Wealth Group, exiting entirely with an estimated $454K sold.

  • 68 institutional investors held Matinas BioPharma (MTNB) as of Q1 2020, up from 64 in Q4 2019.
  • Funds reported $34.4M of Matinas BioPharma stock for Q1 2020, down 49% quarter-over-quarter.
  • 14 funds opened new Matinas BioPharma positions in Q1 2020 and 8 closed out, a net change of +6 holders.
  • The largest Matinas BioPharma buyer in Q1 2020 was Vivo Capital, an estimated $13.6M added.
  • The largest Matinas BioPharma seller in Q1 2020 was CIBC Private Wealth Group, an estimated $454K sold.

Based on aggregated 13F filings for Q1 2020.